BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24604277)

  • 1. Do predictive parameters exist for therapy with duloxetine in women with stress urinary incontinence?
    Schwertner-Tiepelmann N; Schwab F; Tunn R
    Int Urogynecol J; 2014 Aug; 25(8):1071-9. PubMed ID: 24604277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
    Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
    Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
    Cardozo L; Drutz HP; Baygani SK; Bump RC
    Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
    Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
    Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine.
    Vella M; Duckett J; Basu M
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):961-4. PubMed ID: 18231697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in Germany.
    Manning M; Gotsch U; Minarzyk A; Quail D; Gross A; Pages I; Methfessel HD; Michel MC
    Int J Clin Pract; 2009 Dec; 63(12):1724-33. PubMed ID: 19930333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of duloxetine in women with stress urinary incontinence.
    Oelke M; Roovers JP; Michel MC
    BJOG; 2006 May; 113 Suppl 1():22-6. PubMed ID: 16529566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Place of duloxetine in the treatment of stress urinary incontinence].
    Rouprêt M; Richard F; Chartier-Kastler E
    Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The 10-minute consultation. Urinary incontinence in a woman].
    Kolben M; Maurer S; Knitza R
    MMW Fortschr Med; 2004 Jul; 146(29-30):59-60. PubMed ID: 15540565
    [No Abstract]   [Full Text] [Related]  

  • 19. Duloxetine in women awaiting surgery.
    Drutz H
    BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.